Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

New nanocarriers improve drug delivery for disease treatment.

Skin reactions from cancer treatments might predict how well the treatments work.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

Dermoscopy is effective for diagnosing various skin infestations and infections.

Dermoscopy improves diagnosis of hair and scalp disorders and can help avoid unnecessary biopsies.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

NIH dermatology funding increased by 14.7% from 2015 to 2019, but men and certain states and institutions received most of the money.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

About 11% of patients with secondary syphilis had Syphilitic Alopecia, which usually improved with treatment.

White blood cells and their traps can slow down the process of new hair growth after a wound.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

The document concludes that the acoustic coupler SF-001 is good for skin ultrasound, especially on rough body parts, because it's stable and shows blood vessels well.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Undiagnosed lupus can cause severe complications after epidural anesthesia, leading to muscle weakness and potentially death.